BCKDK and colorectal carcinoma: To further confirm these results, 3,6-dichlorobrenzo(b)thiophene-2-carboxylic acid (BT2), a small-molecule inhibitor of BCKDK [10, 38], was employed to determine the role of BCKDK in CRC.